The Internet of Medical Things is moving beyond device connectivity into continuous, data-driven care delivery.

Healthcare providers are using real-time data, AI and clinical-grade wearables to detect risk earlier, intervene faster and manage patients more effectively.

What began as remote monitoring is now becoming a core part of how healthcare systems operate and compete.

According to Visiongain analysis, the global Internet of Medical Things market is valued at US$175 billion in 2025 and is projected to reach US$1,053.9 billion by 2035, growing at a CAGR of 19.6%.

Visiongain Top Takeaways

• Interoperability Is Becoming a Competitive Priority: Seamless data exchange across devices, platforms and providers is emerging as a key differentiator.
• AI Integration Is Improving Clinical Decision-Making: Machine learning is converting large volumes of patient data into actionable, real-time insights.
• Cybersecurity Is Moving Up the Agenda: Rising data risks are driving investment in secure, compliant digital health infrastructure.
• Chronic Disease Is Driving Demand: Diabetes, cardiovascular and respiratory conditions are increasing the need for continuous monitoring.
• Emerging Markets Are Expanding the Opportunity: Growth in digital health infrastructure across Asia-Pacific, Latin America and Africa is opening new markets.
• Regulatory Clarity Is Supporting Adoption: More defined digital health frameworks are reducing uncertainty and enabling faster deployment.

IoMT Is Moving into Core Healthcare Delivery

IoMT is becoming central to how healthcare is delivered and managed. Continuous monitoring, predictive analytics and connected workflows are now contributing to measurable improvements in clinical outcomes and operational efficiency. This is supporting a broader move towards more data-driven, value-based models of care, with IoMT now embedded within clinical pathways rather than operating alongside them.

Adoption remains uneven across regions, but healthcare providers, insurers and payers are aligning around interoperability, reimbursement and cybersecurity requirements. Advanced IoMT solutions are developing alongside traditional monitoring systems, creating a dual-layer market. However, system compatibility and data fragmentation remain constraints in scaling these solutions.

Visiongain Insight: IoMT is not replacing traditional monitoring. It is creating a new competitive layer where data integration, security, and clinical outcomes determine which organisations can deliver care more effectively at scale.

Wearables Are Moving into Clinical Use

Wearables have moved beyond consumer wellness into clinical application. Devices such as smartwatches, biosensor patches, connected glucose monitors and cardiac monitoring systems are supporting continuous, real-time patient monitoring and earlier intervention.

Clinical-grade wearable technologies developed by leading device and technology companies such as Apple and Medtronic are increasingly being integrated into care environments.

These technologies are contributing to reduced hospital admissions, improved disease management and better patient engagement across hospital and home settings, while also supporting broader population health management.

Healthcare providers, insurers and governments are recognising wearables as cost-effective tools for managing chronic conditions and supporting recovery. At the same time, clearer reimbursement pathways and growing patient acceptance are supporting wider adoption. However, integrating wearable data into clinical workflows and existing health systems remains a key operational challenge.

Visiongain Insight: Organisations that can effectively integrate wearable data into clinical workflows will be better positioned to improve outcomes, manage costs and scale remote care delivery.

Insurers Are Becoming Active Participants in Care

Health insurers are moving beyond their traditional role as payers. Many are integrating connected devices into care models to monitor patients, identify risks earlier and reduce long-term costs.

Devices such as connected glucose monitors, smart inhalers and remote blood pressure systems are enabling insurers to move towards more preventative models of care. This is influencing underwriting, pricing and engagement strategies, while improving risk selection and long-term claims management. In some cases, insurers are also linking these programmes to incentives and personalised pricing models to influence patient behaviour.

Programmes based on continuous monitoring are showing measurable impact, including reduced hospitalisation rates and improved adherence. At the same time, insurers are investing in data security, interoperability and regulatory compliance to support these models.

Visiongain Insight: Insurers are moving towards a more active role in healthcare delivery, using connected devices to link prevention, monitoring and reimbursement, and to manage risk more effectively over time.

Market Dynamics Are Accelerating

IoMT is becoming one of the most commercially active areas within healthcare, attracting more investment as the market expands. Growth is being driven by the prevalence of chronic diseases, ageing populations, rising healthcare costs and demand for preventive care.

Regional dynamics vary. North America remains the most mature market, supported by strong reimbursement systems and established infrastructure. Asia-Pacific is growing rapidly, driven by government investment, expanding healthcare access and digital infrastructure, including wider 5G deployment. Europe is progressing steadily, supported by regulatory frameworks and the integration of public healthcare systems.

Leading companies are strengthening their positions across both medical technology and digital infrastructure:

• Medtronic is expanding remote monitoring in cardiac and diabetes care
• Philips Healthcare is developing hospital-to-home connected care platforms
• Apple is advancing wearable diagnostics with regulatory clearance
• GE HealthCare is investing in connected imaging and monitoring
• Amazon Web Services and Google are expanding their role in healthcare data infrastructure and analytics

Visiongain Insight: Companies that combine scalable infrastructure, secure data integration and clinical validation will be best positioned to capture value as the market expands, while those unable to integrate and deploy these systems effectively risk falling behind.

Market Outlook: Growth with Structural Constraints

The IoMT market is expected to expand rapidly over the next decade, supported by strong demand for remote monitoring, preventive care and data-driven healthcare delivery.

However, growth will not be uniform. The ability to embed IoMT into clinical pathways, manage large volumes of patient data and meet regulatory requirements will shape the pace of adoption.

Healthcare systems are under pressure to deliver more efficient care at lower cost. IoMT has the potential to support this, but only when deployed at scale and aligned with existing infrastructure.

Visiongain Insight: The organisations that succeed will be those that can move beyond pilot programmes and operationalise IoMT at scale, combining data integration, clinical validation and execution capability.

From Visiongain

Visiongain’s Internet of Medical Things (IoMT) Market Report 2025–2035 examines how connected devices, data integration and digital health platforms are shaping the next phase of healthcare delivery.

The report explores market growth across key regions, the role of AI and wearables in clinical care, and how leading organisations are positioning to scale IoMT solutions within increasingly complex healthcare systems.

To understand where long-term value will be created and how organisations are building competitive advantage, request sample pages.

Latest Reports

Detailed market forecasts, competitive analysis, and sector insights help R&D, manufacturing, supply chain, and commercial teams make decisions.

• Vaccine Contract Manufacturing Market Report 2026-2036
• Decentralised Clinical Trials Market Report 2026-2036
• Cell & Gene Therapy Market Report 2026-2036
• Alzheimer’s Therapeutics Market Report 2026-2036
• Anti-obesity Drugs Market Report 2026-2036
• Longevity Market Report 2026-2036

Press & Media Enquiries

For commentary, data requests or interview enquiries, please contact: press@visiongain.com